Strata Skin Sciences, Inc.
SSKN
$2.20
-$0.0636-2.81%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.86% | 10.21% | -0.62% | 2.24% | -10.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.86% | 10.21% | -0.62% | 2.24% | -10.74% |
| Cost of Revenue | -13.85% | -1.77% | -10.47% | -11.04% | 15.57% |
| Gross Profit | 18.41% | 19.91% | 7.13% | 14.34% | -29.81% |
| SG&A Expenses | -2.83% | 6.19% | 26.24% | -11.55% | -13.98% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.46% | 0.98% | 10.38% | -12.64% | -5.02% |
| Operating Income | 30.25% | 68.37% | -168.78% | 75.23% | -11.72% |
| Income Before Tax | 27.79% | -20.10% | -101.52% | 96.86% | -18.80% |
| Income Tax Expenses | -- | -84.78% | -- | -- | -- |
| Earnings from Continuing Operations | 27.79% | -18.53% | -101.52% | 96.86% | -18.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 27.79% | -18.53% | -101.52% | 96.86% | -18.80% |
| EBIT | 30.25% | 68.37% | -168.78% | 75.23% | -11.72% |
| EBITDA | 51.52% | 608.20% | -149.64% | 243.07% | -37.93% |
| EPS Basic | 39.30% | 0.54% | -74.20% | 96.88% | -18.13% |
| Normalized Basic EPS | 39.31% | 57.78% | -74.22% | 57.20% | -18.12% |
| EPS Diluted | 39.30% | 0.54% | -74.20% | 96.88% | -18.13% |
| Normalized Diluted EPS | 39.31% | 57.78% | -74.22% | 57.20% | -18.12% |
| Average Basic Shares Outstanding | 18.97% | 19.17% | 15.69% | 0.51% | 0.57% |
| Average Diluted Shares Outstanding | 18.97% | 19.17% | 15.69% | 0.51% | 0.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |